Corona vaccine: Biontech and Pfizer apply for approval in the EU

The Mainz-based company Biontech and the US pharmaceutical group Pfizer applied for approval of their corona vaccine in the EU and the USA on Monday.

• The German company

  Biontech

  and its US partner

  Pfizer

  have developed a

  corona vaccine *

  .

• On Monday, the companies

  applied for

  approval

  in the

  EU

  .

• The

  Biontech / Pfizer vaccine *

  has an

  effectiveness of 95 percent

  , according to the company

  .

Mainz / New York - Mainz-based company

and its US partner

have applied to the European Medicines Agency

(EMA) for

in the

.

The application for a conditional marketing authorization was submitted on Monday, announced Biontech and Pfizer on Tuesday.

On Monday, the US company

submitted a corresponding application for its vaccine to the EMA.

Corona vaccine: Biontech / Pfizer apply for approval in the EU and the USA

The

must now examine the applications.

How long this would take was initially unclear.

If the authority recommends conditional approval, the vaccine could

,

.

The final decision is made by the EU Commission, which usually follows the EMA recommendation.

Biontech had announced that it would

be able to start

immediately after approval

.

Biontech / Pfizer and Moderna have also

filed for

with the

.

For the

with the designation

, extensive test series showed an

that

offers

against the disease

,

according to the companies

.

The vaccine worked similarly well across all age groups and other demographic differences and showed

, the companies said after the final analysis.

The

for people who are over 65 years old is over

.

It

is not yet clear to

what extent the vaccine also protects against

and possible transmission of the

.

We have submitted a formal Application for Conditional Marketing Authorization to @EMA_News for #mRNA vaccine candidate # BNT162b2 against # COVID19.

It will be assessed according to # EMA's normal stringent standards for quality, safety and efficacy.

https://t.co/Sn1n4oJZ6S pic.twitter.com/2sadnJJLp9

- BioNTech SE (@BioNTech_Group) December 1, 2020

Corona vaccine: Germany and EU with a framework agreement for the purchase of up to 300 million doses

"As a company based in the heart of Europe, today's

is immensely important to us as we continue to strive to enable global distribution after the potential approval of BNT162b2," said Biontech CEO and co-founder

.

“We want to continue to work with

around the world

to enable

our

approved

.

We would like to contribute to the global efforts to fight the virus in order to return to

. "

Germany

and the

have already signed a framework agreement * for the purchase of

.

Based on delivery

,

assumes that

will be

shipped

worldwide this year

and

will be manufactured

next year

.